Intratumoral delivery of an interferon gamma retrovirus-producing cells inhibits growth of a murine melanoma by a non-immune mechanism

Cancer Letters

Volumn 173, Issue 2, 2001, Pages 145-154

  Yu, Duonan ^a   Thomas Tikhonenko, Andrei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Interferon gamma; Melanoma; Retroviral vectors

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; GAMMA INTERFERON;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RATE; MELANOMA; MELANOMA CELL; MITOSIS INDEX; MITOSIS RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; IN SITU NICK-END LABELING; INTERFERON TYPE II; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MITOSIS; RETROVIRIDAE; THYMIDINE; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0035965581     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00612-7     Document Type: Article

References (44)

1. Immune-inflammatory mechanisms in IFN gamma-mediated anti-tumor activity
2. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor
3. Macrophage tumoricidal mechanisms
4. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice
5. Interferon therapy in cancer: From imaginon to interferon
6. Transfection of interferon-gamma gene in animal tumors - A model for local cytokine production and tumor immunity
7. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
8. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor
9. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells
10. Cellular responses to interferon-gamma
11. How cells respond to interferons
12. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis
13. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
14. Inhibition of angiogenesis in vivo by interleukin 12
15. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
16. Inhibitory effects of cytokines on vascular endothelial cells: Synergistic interactions among interferon-gamma, tumor necrosis factor-alpha, and interleukin-1
17. Inhibition of endothelial cell proliferation by gamma-interferon
18. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
19. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo
20. Systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis
21. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
22. Biological behavior of malignant melanoma cells correlated to their survival in vivo
23. Construction and use of a safe and efficient amphotropic packaging cell line
24. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death
25. A severe combined immunodeficiency mutation in the mouse
26. Role of NK cells in tumour growth and metastasis in beige mice
27. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma
28. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
29. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas
30. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen
31. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro
32. Interferon-gamma and chronic granulomatous disease
33. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity
34. A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8 + T cells against the wild-type tumor: Correlation with antigen presentation capability
35. Antitumor potential of interferon-gamma: Retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity
36. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice
37. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice
38. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis
39. Gene therapy death prompts review of adenovirus vector
40. Generation of a systemic antitumor response with regional intratumoral injections of interferon gamma retroviral vector
41. Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma
42. Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma
43. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
44. Transgenic mouse model of malignant skin melanoma